Timothy H Witney Selected Research

Timothy H Witney Research Topics

Disease

26	Neoplasms (Cancer) 05/2022 - 06/2009
8	Lymphoma (Lymphomas) 01/2017 - 06/2009
5	Necrosis 01/2014 - 11/2009
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
3	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2014
2	Glioma (Gliomas) 01/2017 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 10/2015
1	Lung Diseases (Lung Disease) 10/2019
1	Idiopathic Pulmonary Fibrosis 10/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Multiple Sclerosis 02/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2018
1	Nervous System Diseases (Neurological Disorders) 02/2018
1	Lupus Nephritis 08/2012
1	Inflammation (Inflammations) 08/2012
1	Glomerulonephritis 08/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 05/2022 - 05/2010
5	4-(3-fluoropropyl)glutamic acidIBA 01/2022 - 02/2018
5	Pyruvic Acid (Pyruvate)IBA 08/2012 - 06/2009
4	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2018
4	Cystine (L-Cystine)IBA 01/2022 - 02/2018
4	FumaratesIBA 08/2012 - 11/2009
3	AntiportersIBA 01/2022 - 02/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 07/2011 - 06/2009
3	malic acid (malate)IBA 12/2010 - 11/2009
2	Amino Acids FDA Link 01/2022 - 12/2021
2	AcidsIBA 12/2021 - 09/2014
2	AntioxidantsIBA 11/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2014
2	IntegrinsIBA 10/2019 - 08/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2014
2	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2010
2	Synaptotagmin IIBA 01/2017 - 05/2010
2	PhosphatidylserinesIBA 01/2017 - 05/2010
2	Biological ProductsIBA 03/2014 - 02/2012
1	Cisplatin (Platino)FDA LinkGeneric 05/2022
1	LipopolysaccharidesIBA 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2022
1	Cystine-Knot MiniproteinsIBA 10/2019
1	Poly Adenosine Diphosphate RiboseIBA 01/2019
1	talazoparibIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Pertussis ToxinIBA 02/2018
1	Freund's AdjuvantIBA 02/2018
1	ThymidineIBA 01/2018
1	Thymidine PhosphorylaseIBA 01/2018
1	Thymidylate SynthaseIBA 01/2018
1	alovudineIBA 01/2018
1	LactonesIBA 01/2016
1	withaferin AIBA 01/2016
1	diazobenzenesulfonic acid (DASA)IBA 10/2015
1	ML-265IBA 10/2015
1	HexokinaseIBA 10/2015
1	Pyruvate KinaseIBA 10/2015
1	C-SNAT compoundIBA 09/2015
1	EstersIBA 09/2014
1	Carnitine (L-Carnitine)FDA LinkGeneric 09/2014
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2014
1	GlycogenIBA 03/2014
1	Glucosamine (Dona)IBA 03/2014
1	TriazolesIBA 03/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Choline KinaseIBA 02/2012
1	Betaine (C.B.B.)FDA Link 02/2012
1	Choline (Choline Chloride)IBA 02/2012
1	Phosphorylcholine (Phosphocholine)IBA 02/2012
1	EnzymesIBA 07/2011
1	IsotopesIBA 07/2011
1	SuspensionsIBA 07/2011
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2011
1	Contrast MediaIBA 12/2010
1	GlutaminaseIBA 10/2010
1	Glutamine (L-Glutamine)FDA Link 10/2010
1	Proteins (Proteins, Gene)FDA Link 05/2010
1	Annexin A5IBA 05/2010
1	Cysteine (L-Cysteine)FDA Link 05/2010
1	Carrier Proteins (Binding Protein)IBA 05/2010
1	Radioisotopes (Radionuclides)IBA 05/2010
1	Succinic Acid (Succinate)IBA 11/2009
1	Etoposide (VP 16)FDA LinkGeneric 11/2009

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2014
2	Immunotherapy 10/2019 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2019
1	Radiotherapy 01/2019
1	Subcutaneous Injections 02/2018
1	Aftercare (After-Treatment) 12/2010